167 related articles for article (PubMed ID: 36731366)
21. Cancer cell membrane-camouflaged biomimetic nanoparticles for enhancing chemo-radiation therapy efficacy in glioma.
Tang C; Wang Y; Wu M; Wang Z; Zhou Y; Lin Y; Wang Y; Xu H
J Biomed Res; 2024 May; ():1-16. PubMed ID: 38812286
[TBL] [Abstract][Full Text] [Related]
22. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
[TBL] [Abstract][Full Text] [Related]
23. Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment.
Peng Y; Huang J; Xiao H; Wu T; Shuai X
Int J Nanomedicine; 2018; 13():3467-3480. PubMed ID: 29942129
[TBL] [Abstract][Full Text] [Related]
24. Human Cancer Cell Membrane-Coated Biomimetic Nanoparticles Reduce Fibroblast-Mediated Invasion and Metastasis and Induce T-Cells.
Jin J; Krishnamachary B; Barnett JD; Chatterjee S; Chang D; Mironchik Y; Wildes F; Jaffee EM; Nimmagadda S; Bhujwalla ZM
ACS Appl Mater Interfaces; 2019 Feb; 11(8):7850-7861. PubMed ID: 30707559
[TBL] [Abstract][Full Text] [Related]
25. Combined cancer therapeutics-Tackling the complexity of the tumor microenvironment.
Roma-Rodrigues C; Raposo LR; Valente R; Fernandes AR; Baptista PV
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1704. PubMed ID: 33565269
[TBL] [Abstract][Full Text] [Related]
26. Biomimetic Nanocomposites Camouflaged with Hybrid Cell Membranes for Accurate Therapy of Early-Stage Glioma.
Chi S; Zhang L; Cheng H; Chang Y; Zhao Y; Wang X; Liu Z
Angew Chem Int Ed Engl; 2023 Jul; 62(29):e202304419. PubMed ID: 37199033
[TBL] [Abstract][Full Text] [Related]
27. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
[TBL] [Abstract][Full Text] [Related]
28. Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response.
Yin P; Li H; Ke C; Cao G; Xin X; Hu J; Cai X; Li L; Liu X; Du B
Int J Nanomedicine; 2020; 15():1499-1515. PubMed ID: 32189965
[TBL] [Abstract][Full Text] [Related]
29. Homotypic Cancer Cell Membranes Camouflaged Nanoparticles for Targeting Drug Delivery and Enhanced Chemo-Photothermal Therapy of Glioma.
Ren Y; Miao C; Tang L; Liu Y; Ni P; Gong Y; Li H; Chen F; Feng S
Pharmaceuticals (Basel); 2022 Jan; 15(2):. PubMed ID: 35215270
[TBL] [Abstract][Full Text] [Related]
30. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
Yang M; Li J; Gu P; Fan X
Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
[TBL] [Abstract][Full Text] [Related]
31. Macrophage-Membrane-Coated Nanoparticles for Tumor-Targeted Chemotherapy.
Zhang Y; Cai K; Li C; Guo Q; Chen Q; He X; Liu L; Zhang Y; Lu Y; Chen X; Sun T; Huang Y; Cheng J; Jiang C
Nano Lett; 2018 Mar; 18(3):1908-1915. PubMed ID: 29473753
[TBL] [Abstract][Full Text] [Related]
32. L-Carnitine-conjugated nanoparticles to promote permeation across blood-brain barrier and to target glioma cells for drug delivery via the novel organic cation/carnitine transporter OCTN2.
Kou L; Hou Y; Yao Q; Guo W; Wang G; Wang M; Fu Q; He Z; Ganapathy V; Sun J
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1605-1616. PubMed ID: 28974108
[TBL] [Abstract][Full Text] [Related]
33. Engineered Cell Membrane-Coated Nanoparticles: New Strategies in Glioma Targeted Therapy and Immune Modulation.
Ma Y; Yi J; Ruan J; Ma J; Yang Q; Zhang K; Zhang M; Zeng G; Jin L; Huang X; Li J; Yang H; Wu W; Sun D
Adv Healthc Mater; 2024 Apr; ():e2400514. PubMed ID: 38652681
[TBL] [Abstract][Full Text] [Related]
34. Cancer Cell Membrane-Enveloped Dexamethasone Normalizes the Tumor Microenvironment and Enhances Gynecologic Cancer Chemotherapy.
Li M; Wang Y; Zhang L; Liu Q; Jiang F; Hou W; Wang Y; Fang H; Zhang Y
ACS Nano; 2023 Sep; 17(17):16703-16714. PubMed ID: 37603464
[TBL] [Abstract][Full Text] [Related]
35. Exploiting a New Approach to Destroy the Barrier of Tumor Microenvironment: Nano-Architecture Delivery Systems.
Sun Y; Li Y; Shi S; Dong C
Molecules; 2021 May; 26(9):. PubMed ID: 34062992
[TBL] [Abstract][Full Text] [Related]
36. Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma.
Ling Y; Wei K; Zou F; Zhong S
Int J Pharm; 2012 Jul; 430(1-2):266-75. PubMed ID: 22486964
[TBL] [Abstract][Full Text] [Related]
37. TME-Related Biomimetic Strategies Against Cancer.
Peng C; Xu Y; Wu J; Wu D; Zhou L; Xia X
Int J Nanomedicine; 2024; 19():109-135. PubMed ID: 38192633
[TBL] [Abstract][Full Text] [Related]
38. Dual-Targeting Magnetic PLGA Nanoparticles for Codelivery of Paclitaxel and Curcumin for Brain Tumor Therapy.
Cui Y; Zhang M; Zeng F; Jin H; Xu Q; Huang Y
ACS Appl Mater Interfaces; 2016 Nov; 8(47):32159-32169. PubMed ID: 27808492
[TBL] [Abstract][Full Text] [Related]
39. Biomembrane camouflaged nanoparticles: A paradigm shifts in targeted drug delivery system.
Qureshi SA; Rafiya K; Awasthi S; Jain A; Nadaf A; Hasan N; Kesharwani P; Ahmad FJ
Colloids Surf B Biointerfaces; 2024 Jun; 238():113893. PubMed ID: 38631282
[TBL] [Abstract][Full Text] [Related]
40. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting.
Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y
Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
